Kothari Fermentation & Biochem Ltd

On 24-Nov, Kothari Fermentation & Biochem Ltd witnessed a significant decline in its share price, closing at ₹44.00, down ₹3.82 or 7.99% from the previous close. This drop reflects a continuation of the stock's underperformance relative to broader market indices and sector peers.

As of 18-Nov, Kothari Fermentation & Biochem Ltd's stock price is Rs 46.05, down 3.84%, and has underperformed its sector. The stock has declined 4.95% over the last three days and 38.60% year-to-date, contrasting sharply with the Sensex's 8.36% increase.

As of November 17, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -26.22, high EV to EBITDA of 12.88, low ROCE of 2.23%, and negative ROE of -5.24%, significantly underperforming compared to peers and the Sensex.

Kothari Ferment's historical performance shows a recovery in Mar'25, with net sales rising to 114.23 Cr and operating profit improving to 11.87 Cr, compared to previous losses. Total assets and liabilities decreased, while cash flow from operations increased to 10.00 Cr.

As of November 7, 2025, Kothari Ferment. is considered very attractive due to its significant undervaluation with a PE ratio of -52.17, an EV to EBITDA of 11.09, and a low PEG ratio of 0.00, despite a year-to-date stock performance lagging at -34.61% compared to the Sensex's 6.50%.

As of November 7, 2025, Kothari Ferment. is considered very attractive and undervalued compared to peers, with a PE ratio of -52.17, an EV to EBITDA of 11.09, and a Price to Book Value of 1.30, despite a -49.88% return over the past year, suggesting potential for recovery in the FMCG sector.

As of November 7, 2025, Kothari Ferment. is considered very attractive due to its undervalued status, highlighted by a negative PE ratio of -52.17 and a PEG ratio of 0.00, making it a compelling investment opportunity compared to its peers like Hindustan Unilever and Nestle India, which have much higher valuations.

As of November 6, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -52.52 and an EV to EBITDA of 11.14, despite trading at a discount compared to peers like Hindustan Unilever and Nestle India, while its stock has underperformed the Sensex with a year-to-date return of -34.17%.

As of October 27, 2025, Kothari Ferment. is considered very attractive and undervalued due to its negative PE ratio of -51.79 and favorable valuation metrics compared to peers, despite a year-to-date stock return of -35.09%.

As of October 17, 2025, Kothari Ferment. is considered overvalued with a negative PE ratio of -54.22 and a ROE of -2.49%, contrasting unfavorably with peers like Hindustan Unilever and Nestle India, despite a recent short-term stock outperformance against the Sensex.

As of October 17, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -54.22, a price-to-book value of 1.35, and an EV to EBITDA ratio of 11.38, significantly underperforming its peers and the market.

As of October 17, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -54.22 and a year-to-date return of -32.04%, contrasting with the positive performance of its peers like Hindustan Unilever and Nestle India.

As of October 1, 2025, Kothari Ferment. is considered very attractive with a PE ratio of -50.91 and an EV to EBITDA of 10.92, despite a year-to-date return of -36.19%, indicating significant undervaluation compared to peers like Hindustan Unilever and Nestle India.

As of October 1, 2025, Kothari Ferment. is rated very attractive due to its undervalued status, indicated by a PE ratio of -50.91 and a PEG ratio of 0.00, despite a year-to-date decline of -36.19% compared to the Sensex's 3.64%.

As of 24-Sep, Kothari Fermentation & Biochem Ltd is priced at Rs 49.40, having gained slightly over the last three days but remains significantly down 46.77% over the past year. The company faces challenges with weak fundamentals, high debt, and declining promoter confidence, underperforming the benchmark Sensex year-to-date.